GB0623732D0 — Powder delivery devices
Assigned to Optinose AS · Expires 2007-01-10 · 19y expired
What this patent protects
A nasal delivery device for delivering particulate substance to the nasal airway of a subject, the delivery device comprising: a mouthpiece unit (109) which includes a mouthpiece (147) through which the subject in use exhales; a nosepiece unit (105) which includes a nosepiece (14…
USPTO Abstract
A nasal delivery device for delivering particulate substance to the nasal airway of a subject, the delivery device comprising: a mouthpiece unit (109) which includes a mouthpiece (147) through which the subject in use exhales; a nosepiece unit (105) which includes a nosepiece (141) for fitting to a nostril of the subject; and a substance-supply unit (111) which is configured to receive a container (C) containing particulate substance and operable to provide a metered amount of substance in fluid communication with the mouthpiece and nosepiece units (109, 105), such that an exhalation air flow delivered through the substance-supply unit (111) entrains the substance; wherein the container (C) comprises first and second parts (115, 117) which together define an enclosed chamber (119) and are movable between a first, closed configuration in which the container (C) is closed and a second, open configuration in which the container (C) is open, and the substance-supply unit (111) is operable to move the first and second parts (115, 117) of the container (C) to the open configuration.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.